Literature DB >> 8464803

Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.

D E Bugay1.   

Abstract

The theory of solid-state nuclear magnetic resonance (NMR) spectroscopy is reviewed, with specific discussions of magnetic interactions in the solid state. Each magnetic interaction (Zeeman, dipole-dipole, chemical-shift, spin-spin, and quadrupolar) is addressed and manifestations of these interactions in the solid state NMR spectrum are explained. The techniques of high-power decoupling, magic-angle spinning, and cross-polarization, used to acquire highly resolved solid-state NMR spectra, are also illustrated. Application of solid-state NMR to pharmaceutical problem solving and methods development is then briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464803     DOI: 10.1023/a:1018967717781

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Solid-state phase transitions initiated by water vapor sorption of crystalline L-660,711, a leukotriene D4 receptor antagonist.

Authors:  E B Vadas; P Toma; G Zografi
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 2.  Newer ACE inhibitors. A look at the future.

Authors:  A Salvetti
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 3.  Physical characterization of pharmaceutical solids.

Authors:  H G Brittain; S J Bogdanowich; D E Bugay; J DeVincentis; G Lewen; A W Newman
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

4.  Effects of the mechanical energy of multi-tableting compression on the polymorphic transformations of chlorpropamide.

Authors:  M Otsuka; T Matsumoto; N Kaneniwa
Journal:  J Pharm Pharmacol       Date:  1989-10       Impact factor: 3.765

5.  Conformation of glyburide in the solid state and in solution.

Authors:  S R Byrn; A T McKenzie; M M Hassan; A A Al-Badr
Journal:  J Pharm Sci       Date:  1986-06       Impact factor: 3.534

Review 6.  Pharmaceutical applications of polymorphism.

Authors:  J Haleblian; W McCrone
Journal:  J Pharm Sci       Date:  1969-08       Impact factor: 3.534

7.  High-resolution solid-state carbon-13 nuclear magnetic resonance spectra of mofebutazone, phenylbutazone, and oxyphenbutazone in relation to X-ray crystallographic data.

Authors:  M Stoltz; D W Oliver; P L Wessels; A A Chalmers
Journal:  J Pharm Sci       Date:  1991-04       Impact factor: 3.534

8.  Quantitation of the relative amounts of anhydrous carbamazepine (C15H12N2O) and carbamazepine dihydrate (C15H12N2O.2H2O) in a mixture by solid-state nuclear magnetic resonance (NMR).

Authors:  R Suryanarayanan; T S Wiedmann
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

9.  Solid-state chemistry and crystal structure of cefaclor dihydrate.

Authors:  H Martinez; S R Byrn; R R Pfeiffer
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

10.  Analysis of solid-state Carbon-13 NMR spectra of polymorphs (benoxaprofen and nabilone) and pseudopolymorphs (cefazolin).

Authors:  S R Byrn; G Gray; R R Pfeiffer; J Frye
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

  10 in total
  6 in total

1.  Solid-state fluorescence studies of some polymorphs of diflunisal*.

Authors:  Harry G Brittain; Bruce J Elder; Paul K Isbester; Allen H Salerno
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

2.  Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using 13C CP/MAS NMR.

Authors:  P Gao
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

3.  Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.

Authors:  K Kimura; F Hirayama; H Arima; K Uekama
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

Review 4.  Pharmaceutical solids: a strategic approach to regulatory considerations.

Authors:  S Byrn; R Pfeiffer; M Ganey; C Hoiberg; G Poochikian
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

5.  Nuclear magnetic resonance and infrared spectroscopic analysis of nedocromil hydrates.

Authors:  L R Chen; B E Padden; S R Vippagunta; E J Munson; D J Grant
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

6.  Solid-state emulsions: evaluation by 1H and 13C solid-state nuclear magnetic resonance.

Authors:  M L Shively; S F Dec
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.